Treatment with gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial (vol 15, pg 1490, 2000)
G. Borm et B. Mannaerts, Treatment with gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial (vol 15, pg 1490, 2000), HUM REPR, 15(8), 2000, pp. 1877-1877